Downstream process development considerations to address polysorbate degradation in drug substance formulation

被引：0
|
作者：
Yigzaw, Yinges [1 ]
Morris, Alex [1 ]
Sawant, Manali [1 ]
Gu, Jie [1 ]
机构：
[1] Genentech Inc, Purificat, San Francisco, CA 94080 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 253卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
163-BIOT
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Rapid Polysorbate 80 Degradation by Liver Carboxylesterase in a Monoclonal Antibody Formulated Drug Substance at Early Stage Development
    Zhang, Sisi
    Xiao, Hui
    Molden, Rosalynn
    Qiu, Haibo
    Li, Ning
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 109 (11) : 3300 - 3307
  • [2] Pediatric drug development: formulation considerations
    Ali, Areeg Anwer
    Charoo, Naseem Ahmad
    Abdallah, Daud Baraka
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2014, 40 (10) : 1283 - 1299
  • [3] Integrating chemistry process development with downstream considerations
    Miller, DC
    Davis, JF
    FIFTH INTERNATIONAL CONFERENCE ON FOUNDATIONS OF COMPUTER-AIDED PROCESS DESIGN, 2000, 96 (323): : 419 - 422
  • [4] Isolation and characterization of degradation impurities in docetaxel drug substance and its formulation
    Kumar, Dinesh
    Tomar, Rajesh Singh
    Deolia, Santosh Kumar
    Mitra, Moloy
    Mukherjee, Rama
    Burman, Anand C.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (04) : 1228 - 1235
  • [5] Accelerating process development by establishing drug substance development platform
    Rainone, G.
    Podicheti, N. S.
    Mateos, C. O.
    van Mol, R.
    Lee, Q.
    Desai, R.
    Jiang, Y.
    Ahamed, T.
    Ljubovic-Couteau, E.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A109 - A110
  • [6] Key Considerations in Targeted Protein Degradation Drug Discovery and Development
    Qin, Liena
    Dai, Han
    Wang, Junfeng
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [7] Antibody drug conjugates: Process development and analytical considerations
    Hay, Michael
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [8] Development and Validation of Stability Indicating HPLC Method for the Determination of Process and Degradation Related Impurities in Telmisartan Drug Substance
    Ganni, Balakrishna
    Kumar, Rajesh
    Jain, Mohit
    Kumar, B. Vijaya
    Shrivastava, Sujeet
    Kumar, Pramod
    CHEMICAL METHODOLOGIES, 2019, 3 (02): : 145 - 165
  • [9] High-Throughput process development in rAAV drug substance manufacturing
    Jiang, Y.
    Pesic, M.
    Cueto-Rojas, H. F.
    Mishra, V.
    Demirtas, U.
    Ahamed, T.
    Ljubovic-Couteau, E.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A147 - A147
  • [10] Process Development and Robust Control of Physical Attributes of an Amorphous Drug Substance
    Zarkadas, Dimitrios
    Pridgen, Christopher S.
    Liotta, Vincenzo
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (01) : 217 - 230
12345